Walleye Capital’s Accendra Health ACH Stock Holding History

Walleye Capital’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,500	Closed	-$63K	–	4806
2025 Q4	$63K	Buy	22,500 +10,700	+91%	+$38.2K	﹤0.01%	4026
2025 Q3	$56.6K	Sell	11,800 -56,000	-83%	-$356K	﹤0.01%	3960
2025 Q2	$617K	Buy	67,800 +60,300	+804%	+$444K	﹤0.01%	2467
2025 Q1	$67.7K	Buy	+7,500	New	+$79.2K	﹤0.01%	3762
2023 Q3	–	Sell	-6,600	Closed	-$126K	–	5195
2023 Q2	$126K	Sell	6,600 -8,300	-56%	-$148K	﹤0.01%	3337
2023 Q1	$217K	Buy	+14,900	New	+$267K	﹤0.01%	2409
2022 Q4	–	Sell	-6,100	Closed	-$147K	–	3507
2022 Q3	$147K	Buy	+6,100	New	+$188K	﹤0.01%	2260
2019 Q4	–	Sell	-2,300	Closed	-$13K	–	2135
2019 Q3	$13K	Buy	+2,300	New	+$10.3K	﹤0.01%	1760

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's ACH Position: Q1 2026 in Review

Walleye Capital reduced its Accendra Health (ACH) stake by 98% in Q1 2026, selling an estimated $1.37M and leaving 12,000 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4026.

Walleye Capital first reported a position in ACH in Q2 2019 and has held it in 12 quarters since. The position peaked at $2.4M in Q1 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Walleye Capital held 12,000 shares of Accendra Health worth $27.4K as of Q1 2026.
Walleye Capital sold 596,231 Accendra Health shares in Q1 2026, an estimated $1.37M.
Accendra Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4026 holding.
Walleye Capital first reported a position in Accendra Health in Q2 2019 and has held it in 12 quarters since.
Walleye Capital's Accendra Health position peaked at $2.4M in Q1 2025.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.